of 6
Featured News
Some of the leading stories and synthetic biology information from SynbiCITE
10 Sep 2020
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
10 Mar 2020
Fostering a Synthetic Biology standards agenda through the Centre for Engineering Biology, Metrology and Standards
Synthetic biology is seen as having huge potential to cut across different concepts, capabilities and technologies and transform processes within indu...
Synthetic Biology community
Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
COVID-19 - Components to the solution
Professor Richard Kitney discusses vaccines, effective testing for antigens and antibodies, effective diagnosis of the various stages of the disease a...
Fostering a Synthetic Biology standards agenda through the Centre for Engineering Biology, Metrology and Standards
Synthetic biology is seen as having huge potential to cut across different concepts, capabilities and technologies and transform processes within indu...
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
Moving to the World of Digital Biology
Professor Richard Kitney shares his thoughts on engineering biology and its role in today's world. It seems as if at moment coronavirus for COVID-19 i...
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
A New Manufacturing Approach to Vaccine Production
Professor Richard Kitney discusses vaccine production using synthetic biology. So, the major topic of the moment is coronavirus, to which, as we know,...
Synthetic Biology at Scale
Professor Richard Kitney, Co-founder, SynbiTECH, discusses the industrial scaling problem. I recently attended the annual Fellows Day at The Royal Aca...
Engineering a solution to high throughput COVID-19 virus testing in just nine days
SynbiCITE’s London BioFoundry acts on the WHO recommendation of ‘Test, Test, Test’ to show how throughput can be significantly increasedRe-thinking th...
The Power of the DARPA Approach
Professor Richard Kitney shares his thoughts on funding models following the budget announcementIn my blog last week, I was talking about the developm...
The UK SynBio Industry - what does the future hold?
Professor Richard Kitney, Co-founder, SynbiTECH, discusses the UK synbio industry post-Brexit. It’s been an exciting couple of weeks. First, James Fie...